179 related articles for article (PubMed ID: 27736768)
1. Chromosome 5 of Human Pathogen Candida albicans Carries Multiple Genes for Negative Control of Caspofungin and Anidulafungin Susceptibility.
Suwunnakorn S; Wakabayashi H; Rustchenko E
Antimicrob Agents Chemother; 2016 Dec; 60(12):7457-7467. PubMed ID: 27736768
[TBL] [Abstract][Full Text] [Related]
2. Tolerance to Caspofungin in Candida albicans Is Associated with at Least Three Distinctive Mechanisms That Govern Expression of
Yang F; Zhang L; Wakabayashi H; Myers J; Jiang Y; Cao Y; Jimenez-Ortigosa C; Perlin DS; Rustchenko E
Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28223384
[TBL] [Abstract][Full Text] [Related]
3. Multiple Genes of Candida albicans Influencing Echinocandin Susceptibility in Caspofungin-Adapted Mutants.
Sah SK; Bhattacharya S; Yadav A; Husain F; Ndiaye ABKT; Kruppa MD; Hayes JJ; Rustchenko E
Antimicrob Agents Chemother; 2022 Dec; 66(12):e0097722. PubMed ID: 36354349
[TBL] [Abstract][Full Text] [Related]
4. Chromosome 5 monosomy of Candida albicans controls susceptibility to various toxic agents, including major antifungals.
Yang F; Kravets A; Bethlendy G; Welle S; Rustchenko E
Antimicrob Agents Chemother; 2013 Oct; 57(10):5026-36. PubMed ID: 23896475
[TBL] [Abstract][Full Text] [Related]
5. Pyrosequencing to detect mutations in FKS1 that confer reduced echinocandin susceptibility in Candida albicans.
Wiederhold NP; Grabinski JL; Garcia-Effron G; Perlin DS; Lee SA
Antimicrob Agents Chemother; 2008 Nov; 52(11):4145-8. PubMed ID: 18794385
[TBL] [Abstract][Full Text] [Related]
6.
Suwunnakorn S; Wakabayashi H; Kordalewska M; Perlin DS; Rustchenko E
Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29358288
[No Abstract] [Full Text] [Related]
7. Efg1 Controls caspofungin-induced cell aggregation of Candida albicans through the adhesin Als1.
Gregori C; Glaser W; Frohner IE; Reinoso-Martín C; Rupp S; Schüller C; Kuchler K
Eukaryot Cell; 2011 Dec; 10(12):1694-704. PubMed ID: 22037180
[TBL] [Abstract][Full Text] [Related]
8. The role of aneuploidy in the emergence of echinocandin resistance in human fungal pathogen Candida albicans.
Sah SK; Hayes JJ; Rustchenko E
PLoS Pathog; 2021 May; 17(5):e1009564. PubMed ID: 34043737
[No Abstract] [Full Text] [Related]
9. Effects of Echinocandins in Combination with Nikkomycin Z against Invasive Candida albicans Bloodstream Isolates and the
Cheung YY; Hui M
Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28827418
[TBL] [Abstract][Full Text] [Related]
10. [Prevalence of Candida parapsilosis, C. orthopsilosis and C. metapsilosis in candidemia over a 5-year period at Nantes hospital and in vitro susceptibility to three echinocandins by E-test®].
Thierry G; Morio F; Le Pape P; Gay-Andrieu F; Barre O; Miegeville M
Pathol Biol (Paris); 2011 Feb; 59(1):52-6. PubMed ID: 20832195
[TBL] [Abstract][Full Text] [Related]
11. Generation of mutants in Candida albicans with reduced susceptibility to caspofungin: influence on other antifungal products.
Soler L; Rodriguez JC; Belda S; Cremades R; Ruiz-Garcia M; Lopez P; Royo G
J Chemother; 2010 Aug; 22(4):283-4. PubMed ID: 20685636
[No Abstract] [Full Text] [Related]
12. Overexpression of Candida albicans CDR1, CDR2, or MDR1 does not produce significant changes in echinocandin susceptibility.
Niimi K; Maki K; Ikeda F; Holmes AR; Lamping E; Niimi M; Monk BC; Cannon RD
Antimicrob Agents Chemother; 2006 Apr; 50(4):1148-55. PubMed ID: 16569823
[TBL] [Abstract][Full Text] [Related]
13. Caspofungin resistance in Candida albicans: genetic factors and synergistic compounds for combination therapies.
Perrine-Walker F
Braz J Microbiol; 2022 Sep; 53(3):1101-1113. PubMed ID: 35352319
[TBL] [Abstract][Full Text] [Related]
14. A Candida albicans strain with high MIC for caspofungin and no FKS1 mutations exhibits a high chitin content and mutations in two chitinase genes.
Drakulovski P; Dunyach C; Bertout S; Reynes J; Mallié M
Med Mycol; 2011 Jul; 49(5):467-74. PubMed ID: 21108572
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the Sensititre Yeast One microdilution method for susceptibility testing of Candida species to anidulafungin, caspofungin, and micafungin.
García-Agudo L; García-Martos P; Martos-Cañadas J; Aznar-Marín P; Marín-Casanova P; Rodríguez-Iglesias M
Rev Esp Quimioter; 2012 Dec; 25(4):256-60. PubMed ID: 23303256
[TBL] [Abstract][Full Text] [Related]
16. Correlating echinocandin MIC and kinetic inhibition of fks1 mutant glucan synthases for Candida albicans: implications for interpretive breakpoints.
Garcia-Effron G; Park S; Perlin DS
Antimicrob Agents Chemother; 2009 Jan; 53(1):112-22. PubMed ID: 18955538
[TBL] [Abstract][Full Text] [Related]
17. Sensitivity of White and Opaque Candida albicans Cells to Antifungal Drugs.
Craik VB; Johnson AD; Lohse MB
Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28507115
[TBL] [Abstract][Full Text] [Related]
18. Echinocandin resistance due to simultaneous FKS mutation and increased cell wall chitin in a Candida albicans bloodstream isolate following brief exposure to caspofungin.
Imtiaz T; Lee KK; Munro CA; MacCallum DM; Shankland GS; Johnson EM; MacGregor MS; Bal AM
J Med Microbiol; 2012 Sep; 61(Pt 9):1330-1334. PubMed ID: 22653922
[TBL] [Abstract][Full Text] [Related]
19. In vitro study of sequential fluconazole and caspofungin treatment against Candida albicans biofilms.
Sarkar S; Uppuluri P; Pierce CG; Lopez-Ribot JL
Antimicrob Agents Chemother; 2014; 58(2):1183-6. PubMed ID: 24217700
[TBL] [Abstract][Full Text] [Related]
20. Systematic phenotyping of a large-scale Candida glabrata deletion collection reveals novel antifungal tolerance genes.
Schwarzmüller T; Ma B; Hiller E; Istel F; Tscherner M; Brunke S; Ames L; Firon A; Green B; Cabral V; Marcet-Houben M; Jacobsen ID; Quintin J; Seider K; Frohner I; Glaser W; Jungwirth H; Bachellier-Bassi S; Chauvel M; Zeidler U; Ferrandon D; Gabaldón T; Hube B; d'Enfert C; Rupp S; Cormack B; Haynes K; Kuchler K
PLoS Pathog; 2014 Jun; 10(6):e1004211. PubMed ID: 24945925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
